| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/1998 | US5721249 Administering to treat angina |
| 02/24/1998 | US5721248 Calcium agonists; treating cardiovascular disorders |
| 02/24/1998 | US5721247 Neurodegenerative disorders |
| 02/24/1998 | US5721246 Antitumor agents; low toxicity |
| 02/24/1998 | US5721245 4- 3-indolyl!-1H-pyrrolone |
| 02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 02/24/1998 | US5721243 Anticholinergic agents |
| 02/24/1998 | US5721242 Administering a synergistic combination of epiroprim and dapsone |
| 02/24/1998 | US5721241 Enzyme inhibitors, their synthesis, and methods for use |
| 02/24/1998 | US5721240 9-substituted-8-unsubstituted-9-deazaguanines |
| 02/24/1998 | US5721238 2,8-disubstituted quinazolinones |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721236 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 02/24/1998 | US5721235 Pharmaceutical composition containing bromocryptine and use of same for acquired immunodeficiency states |
| 02/24/1998 | US5721229 Soluble forms of cephalosporins and treatment of animals |
| 02/24/1998 | US5721228 Administering topically an effective amount of flunisolide or a flunisolide ester |
| 02/24/1998 | US5721227 17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 02/24/1998 | US5721226 Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives |
| 02/24/1998 | US5721225 Skin disorders; osteoporosis |
| 02/24/1998 | US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds |
| 02/24/1998 | US5721221 Mixing viscosity-controlled aqueous solutions of hydroxypropyl methyl cellulose into foods |
| 02/24/1998 | US5721219 N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation |
| 02/24/1998 | US5721217 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 02/24/1998 | US5721209 Exochelin antioxidants |
| 02/24/1998 | US5720983 Preparing disinfectant composition by mixing aqueous equilibrium solution of lower aliphatic peracid with aqueous solution of hydrogen peroxide, corrosion inhibitor, stabilizer |
| 02/24/1998 | US5720977 Oral water soluble pharmaceutical compositions containing estrone compound and calcium salt |
| 02/24/1998 | US5720975 Use of incense in the treatment of alzheimer's disease |
| 02/24/1998 | US5720966 Medicated tissue paper product |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720948 Non-ionic surfactant emulsion vehicles and their use for deposition of drug into and across skin |
| 02/24/1998 | US5720941 Polymeric particles for dental applications |
| 02/24/1998 | US5720304 Diagnosis by conventional medical technique or bi-digital-o-ring test; having patient ingest antibiotic or antiviral agent, also ingest a herb concentration of umbelliferae family over sustained period of time |
| 02/24/1998 | CA2154103C Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
| 02/24/1998 | CA2086919C Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids |
| 02/24/1998 | CA2075750C Composition and method for treating cancer |
| 02/24/1998 | CA2043071C Heterocyclic compounds |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/21/1998 | CA2213361A1 Stable, long acting salts of carboxamides for the treatment of joint disease |
| 02/19/1998 | WO1998006867A1 A new method for producing pravastatin precursor, ml-236b |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006730A1 Modified oligosaccharides |
| 02/19/1998 | WO1998006724A1 Metabotropic glutamate receptor agonists |
| 02/19/1998 | WO1998006722A1 Thienopyrimidines |
| 02/19/1998 | WO1998006719A1 4-substituted beta-carbolines as immunomodulators |
| 02/19/1998 | WO1998006716A1 Preparation of aminomethyl-phenylimidazoles |
| 02/19/1998 | WO1998006715A1 Novel piperazine containing compounds |
| 02/19/1998 | WO1998006712A1 Neuraminic acid compounds |
| 02/19/1998 | WO1998006711A1 Butyric acid matrix metalloproteinase inhibitors |
| 02/19/1998 | WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 02/19/1998 | WO1998006707A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
| 02/19/1998 | WO1998006705A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 02/19/1998 | WO1998006704A1 Arylalkanoyl pyridazines |
| 02/19/1998 | WO1998006703A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 02/19/1998 | WO1998006701A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006700A1 Stereoselective deoxygenation reaction |
| 02/19/1998 | WO1998006699A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
| 02/19/1998 | WO1998006697A1 Ether muscarinic antagonists |
| 02/19/1998 | WO1998006695A1 Melatonin derivatives and their use in cosmetic or dermopharmaceutical compositions |
| 02/19/1998 | WO1998006694A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 02/19/1998 | WO1998006692A1 Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
| 02/19/1998 | WO1998006690A1 USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM |
| 02/19/1998 | WO1998006689A1 Slow-onset, long-lasting dopamine reuptake blockers |
| 02/19/1998 | WO1998006442A1 Isotopic urea tablets |
| 02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006435A2 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 02/19/1998 | WO1998006433A1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 02/19/1998 | WO1998006418A1 Compositions of plant carbohydrates as dietary supplements |
| 02/19/1998 | WO1998006412A1 A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof |
| 02/19/1998 | WO1998006409A2 Composition containing vitamin a and its use, in particular against skin diseases |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006407A1 Anthelmintic formulations |
| 02/19/1998 | WO1998006406A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
| 02/19/1998 | WO1998006405A1 Stanol composition and the use thereof |
| 02/19/1998 | WO1998006404A1 Combinations for hormone replacement therapy containing a natural oestrogen, a natural progestogen and a natural androgen |
| 02/19/1998 | WO1998006403A1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| 02/19/1998 | WO1998006402A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | WO1998006401A1 Pharmaceutically active compounds and methods of use |
| 02/19/1998 | WO1998006400A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 02/19/1998 | WO1998006399A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006398A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006397A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006396A1 Thrombin inhibitors |
| 02/19/1998 | WO1998006395A1 Topical composition for burn healing |
| 02/19/1998 | WO1998006394A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | WO1998006393A1 Use of efaroxan for producing medicine for treating huntington disease |
| 02/19/1998 | WO1998006392A1 Formulation of 5-ht agonists |
| 02/19/1998 | WO1998006391A1 Pharmaceutical compositions comprising tyrphostins |
| 02/19/1998 | WO1998006390A1 Spontaneously dispersible concentrates of sterol esters and vitamin d derivatives with antiviral, virucidal and/or parasiticidal effect |
| 02/19/1998 | WO1998006389A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 02/19/1998 | WO1998006387A2 Oral composition comprising 5-aminosalicylic acid |
| 02/19/1998 | WO1998006379A1 Pharmaceutical compositions |